Christopher Haqq's most recent trade in Elicio Therapeutics Inc. was a trade of 44,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Elicio Therapeutics Inc. | Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
Elicio Therapeutics Inc. | Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 28,200 | 28,200 | - | - | Stock Option (Right to Buy) | |
Elicio Therapeutics Inc. | Haqq Christopher | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 28,200 | 28,200 | - | - | Stock Option (right to buy) |